Home
Researchers
Paul Fairchild
Co-Director of the Oxford Stem Cell Institute
Addressing the immunological barriers to stem cell therapies.
Colin Goding
Co-Director of the Oxford Stem Cell Institute
Melanocytes, melanoma, stem cells, transcription, signalling and cancer.
Kathryn Wood
Associate of the Oxford Stem Cell Institute
Tolerance, Transplant Immunobiology and Diabetes.
Doug Higgs
Associate of the Oxford Stem Cell Institute
The regulation of gene expression during erythropoiesis.
Marella de Bruijn
Associate of the Oxford Stem Cell Institute
Molecular pathways controlling haemopoietic stem cell generation during ontogeny.
Sten Jacobsen
Associate of the Oxford Stem Cell Institute
Delineation of cellular and molecular pathways of normal and leukemic haematopoietic stem cell fate decisions.
Roger Patient
Associate of the Oxford Stem Cell Institute
Programming blood and the cardiovascular system.
Kieran Clarke
Associate of the Oxford Stem Cell Institute
Adult stem cell therapy for the infarcted rat heart.
Matthew Wood
Associate of the Oxford Stem Cell Institute
Gene therapy for degenerative disorders of the nervous system and muscle.
Francis Szele
Associate of the Oxford Stem Cell Institute
Fundamental features of subventricular zone biology and therapeutic potential.
John Stein
Associate of the Oxford Stem Cell Institute
Visual control of eye and limb movements in animals, neurological patients and dyslexic children
Richard Wade-Martins
Associate of the Oxford Stem Cell Institute
The molecular mechanisms of neurodegenerative disease, including Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy, with a further focus in developing gene therapies.
ZhanFeng Cui
Associate of the Oxford Stem Cell Institute
Tissue engineering and stem cell technology
Suzanne Watt
Associate of the Oxford Stem Cell Institute
Understanding the biology of stem cell development.
Angela Russell and Steve Davies
Departmental Research Lecturer, RCUK Fellow in Medicinal Chemistry
Medicinal Chemistry.
Steven Chance
University Research Lecturer
Dementia, schizophrenia, and the neural basis of language.
Robert MacLaren
Professor of Ophthalmology & Consultant Ophthalmologist
Developing new treatments to prevent blindness
Udo Oppermann
Associate of Oxford Stem Cell Institute
The biology and structure-activity relationships of human metabolic protein families.
Walter Bodmer
Fundamental genetics and biology of colorectal cancer and their potential applications, and the characterisation and population distribution of genetic diversity in human populations, especially of the British Isles.
Paresh Vyas
Transcriptional control of normal and abnormal erythroid and megakaryocytic differentiation
Catherine Porcher
Transcriptional control of haemopoietic stem cell specification and differentiation
Paul Riley
Transcriptional control of heart development and models of congenital heart disease and Resident stem/progenitor cell-derived cardiac repair and regeneration.
Esther Becker
Royal Society Dorothy Hodgkin Research Fellow
Molecular mechanisms governing cerebellar development and disease
Eric O'Neill
Cancer Research UK Junior Group Leader
Our research aim is to validate the extent to which RASSF1A/MST2 signalling contributes to an overall DNA damage response, via p53.
